Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2052 of 5804
-
New hope for elderly myeloma patients: Steroid-Free combo shows promise
Disease control TerminatedMultiple myeloma is an incurable hematological malignancy that affects older patients. Currently, despite recent progress, the disease relapses more or less quickly after initial treatment and requires the resumption of treatment with new drugs associated with cortisone, whose si…
Phase: PHASE2 • Sponsor: University Hospital, Caen • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Massive lung cancer study aims to personalize treatment for thousands
Knowledge-focused Recruiting nowThis screening and multi-sub-study randomized phase II/III trial will establish a method for genomic screening of similar large cancer populations followed by assigning and accruing simultaneously to a multi-sub-study hybrid Master Protocol (Lung-MAP). The type of cancer trait (b…
Phase: PHASE2, PHASE3 • Sponsor: SWOG Cancer Research Network • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
New motorized rod could straighten spines without repeated surgeries
Disease control OngoingThe purpose of this biomedical research is to evaluate the feasibility of the treatment with the new spinal distraction device ASTS in patients aged 4 to 10 years with severe early onset scoliosis. The hypothesis of this project is that the new fully implantable motorized spinal…
Phase: NA • Sponsor: University Hospital, Toulouse • Aim: Disease control
Last updated Jun 26, 2026 15:20 UTC
-
Spine surgery in kids: how well does it hold up over time?
Disease control Recruiting nowThe treatment of child's vertebral malformations has evolved a lot including the realization of surgical vertebral resections. The surgical techniques used are multiple, require heavy surgery, one or more approaches and surgical time, transfusions, a neurological risk (up to 20% …
Sponsor: University Hospital, Tours • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Tiny radiation dose may tame stomach cancer with fewer side effects
Disease control OngoingThis trial studies how well ultra low-dose radiation therapy works in treating patients with stage I-IV stomach mucosa-associated lymphoid tissue (MALT) lymphoma. Ultra low-dose radiation therapy may be able to kill tumor cells and shrink tumors while having fewer side effects in…
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New pill shows promise against lung cancer in early japanese trial
Disease control OngoingThis study is in 2 parts. Different participants will take part in the 1st and 2nd parts of the study. The main aim of the 1st part of the study is to check how much Mobocertinib adults with non-small cell lung cancer (NSCLC) can receive without getting side effects from it. Th…
Phase: PHASE1 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Stroke recovery: could training the 'Good' arm boost independence?
Symptom relief CompletedThis study will test the hypothesis that the combination of low-moderate to severe motor deficits in the paretic arm and persistent motor deficits in the less-impaired arm limits functional independence in chronic stroke survivors. We, therefore, predict that intense remediation,…
Phase: NA • Sponsor: Robert L. Sainburg • Aim: Symptom relief
Last updated Jun 26, 2026 15:28 UTC
-
Battle of the bowel: biofeedback vs. injections for incontinence
Disease control CompletedPatients with severe fecal incontinence (FI), defined as two or more episodes of staining, solid or liquid FI per week, and who meet the inclusion criteria for Injection of Solesta (INJ; an inert bulking agent), or Biofeedback (BIO) will be enrolled. The baseline rate of FI will …
Phase: NA • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New study tracks Real-World use of entyvio in over 1,100 ulcerative colitis patients
Disease control CompletedThe purpose of this survey is to evaluate the long-term safety and effectiveness of vedolizumab for intravenous (IV) infusion 300 milligrams (mg) in ulcerative colitis (UC) patients in the routine clinical setting.
Sponsor: Takeda • Aim: Disease control
Last updated Jun 26, 2026 15:57 UTC
-
Blood test may spot deadly transplant complication earlier
Diagnosis CompletedTo establish risk rating criteria of biological protein marker, determine the role and consistency of aGVHD biomarkers in aGVHD diagnosis and aGVHD prognosis, and evaluate the the impact on non-relapse mortality and relapse and disease free survival, the multicenter study on aGVH…
Sponsor: Chinese PLA General Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:28 UTC
-
8,000-Patient study aims to sharpen cancer radiation with Real-Time MRI
Knowledge-focused Recruiting nowThe Multi-OutcoMe EvaluatioN of radiation Therapy Using the Unity MR-Linac Study (MOMENTUM) is a multi-institutional, international registry facilitating evidenced based implementation of the Unity MR-Linac technology and further technical development of the MR-Linac system with …
Sponsor: UMC Utrecht • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
New antibody takes aim at Hard-to-Treat blood cancers
Disease control OngoingThis phase I trial studies the side effects and best dose of anti-PR1/HLA-A2 monoclonal antibody Hu8F4 (Hu8F4) in treating patients with malignancies related to the blood (hematologic). Monoclonal antibodies, such as Hu8F4, may interfere with the ability of cancer cells to grow a…
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New study tests better comfort care for liver patients
Symptom relief CompletedThis is a comparative effectiveness study of two pragmatic models aiming to introduce palliative care for end stage liver disease patients. The 2 comparators are: Model 1: Consultative Palliative Care (i.e. direct access to Palliative Care provider), Model 2: Trained Hepatologis…
Phase: NA • Sponsor: Albert Einstein Healthcare Network • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Massive study aims to unlock secrets of rare cancers
Knowledge-focused Recruiting nowBackground: Approximately 150 cases of cancer per one million per year are considered rare cancers. While all tumors originate from genetic changes, a small percentage of these tumors are familial. Researchers want to study these changes in biological samples from people with ra…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Blood test may spare Head-Injury patients on blood thinners from unnecessary CT scans
Diagnosis CompletedAll the patients admitted in emergency department for minor traumatized cranial, with antiplatelet therapy, can be included, after checked inclusion and non inclusions criterias. If they are agree, a blood sample for the dosage of S100b will be done. No other modification of the…
Phase: PHASE3 • Sponsor: Poitiers University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
Home-Based weight program aims to curb obesity in mothers
Disease control CompletedThis project evaluates the effectiveness of an evidence-based intervention (HEALTH) to prevent weight gain and promote weight loss when disseminated and implemented in real-world settings, through Parents as Teachers. To enhance the impact of HEALTH, the study also evaluates impl…
Phase: PHASE3 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
900 retinoblastoma survivors join landmark study to uncover Long-Term health secrets
Knowledge-focused Recruiting nowThis trial studies health outcomes after treatment in patients with retinoblastoma. Gathering health information over time from patients and family members through vision assessments, samples of tissue and saliva, and questionnaires may help doctors learn more about what causes r…
Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Knowledge-focused
Last updated Jun 26, 2026 19:15 UTC
-
MS drug holiday for Over-50s: safe or risky?
Disease control OngoingFurther controlled and randomized prospective studies in Multiple sclerosis, analyzing the potential impact of treatment discontinuation on disability progression, focal disease activity and quality of life are needed. The optimum patient age and duration of inactive SPMS before …
Phase: PHASE3 • Sponsor: Rennes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Ultrasound within 12 minutes may predict cardiac arrest outcomes
Knowledge-focused CompletedAssessment of prognostic performances of CCU in CRA Recovery (CRAR) has already been explored but 1) Only in intra-hospital medicine, 2) in very variable timings. ACE Research focuses on the extra-hospital window and predictive value of Early CCU (within 12 minutes of rescucitati…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Blueberry compound may boost cancer treatment in small trial
Disease control OngoingThis phase II trial studies how well megestrol acetate with or without pterostilbene works in treating patients with endometrial cancer undergoing hysterectomy. Drugs used in chemotherapy, such as megestrol acetate, work in different ways to stop the growth of tumor cells, either…
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC